| External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? J Travers, S Marsh, M Williams, M Weatherall, B Caldwell, P Shirtcliffe, ... Thorax 62 (3), 219-223, 2007 | 375 | 2007 |
| Distinct clinical phenotypes of airways disease defined by cluster analysis M Weatherall, J Travers, PM Shirtcliffe, SE Marsh, MV Williams, ... European Respiratory Journal 34 (4), 812-818, 2009 | 322 | 2009 |
| Proportional classifications of COPD phenotypes SE Marsh, J Travers, M Weatherall, MV Williams, S Aldington, ... Thorax 63 (9), 761-767, 2008 | 319 | 2008 |
| Reference ranges for exhaled nitric oxide derived from a random community survey of adults J Travers, S Marsh, S Aldington, M Williams, P Shirtcliffe, A Pritchard, ... American journal of respiratory and critical care medicine 176 (3), 238-242, 2007 | 276 | 2007 |
| Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial M Patel, J Pilcher, A Pritchard, K Perrin, J Travers, D Shaw, S Holt, ... The Lancet Respiratory Medicine 1 (1), 32-42, 2013 | 229 | 2013 |
| COPD prevalence in a random population survey: a matter of definition P Shirtcliffe, M Weatherall, S Marsh, J Travers, A Hansell, A McNaughton, ... European Respiratory Journal 30 (2), 232-239, 2007 | 179 | 2007 |
| External validity of randomized controlled trials in COPD J Travers, S Marsh, B Caldwell, M Williams, S Aldington, M Weatherall, ... Respiratory medicine 101 (6), 1313-1320, 2007 | 164 | 2007 |
| Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD DE O’Donnell, J Travers, KA Webb, Z He, YM Lam, A Hamilton, S Kesten, ... European Respiratory Journal 34 (4), 866-874, 2009 | 140 | 2009 |
| Use of cluster analysis to define COPD phenotypes M Weatherall, P Shirtcliffe, J Travers, R Beasley European respiratory journal 36 (3), 472-474, 2010 | 96 | 2010 |
| Mechanisms of exertional dyspnea in patients with cancer J Travers, DJ Dudgeon, K Amjadi, I McBride, K Dillon, P Laveneziana, ... Journal of Applied Physiology, 2008 | 91 | 2008 |
| Quality of life measured by the St George's Respiratory Questionnaire and spirometry M Weatherall, S Marsh, P Shirtcliffe, M Williams, J Travers, R Beasley European Respiratory Journal 33 (5), 1025-1030, 2009 | 86 | 2009 |
| Use of metered-dose inhaler electronic monitoring in a real-world asthma randomized controlled trial M Patel, J Pilcher, J Travers, K Perrin, D Shaw, P Black, M Weatherall, ... The Journal of Allergy and Clinical Immunology: In Practice 1 (1), 83-91, 2013 | 80 | 2013 |
| Childhood asthma and GOLD‐defined chronic obstructive pulmonary disease P Shirtcliffe, S Marsh, J Travers, M Weatherall, R Beasley Internal medicine journal 42 (1), 83-88, 2012 | 70 | 2012 |
| Time to define the disorders of the syndrome of COPD R Beasley, M Weatherall, J Travers, P Shirtcliffe The Lancet 374 (9691), 670-672, 2009 | 70 | 2009 |
| Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults J Fingleton, J Travers, M Williams, T Charles, D Bowles, R Strik, ... Journal of Allergy and Clinical Immunology 136 (3), 601-609, 2015 | 64 | 2015 |
| Effect of tiotropium bromide on the cardiovascular response to exercise in COPD J Travers, P Laveneziana, KA Webb, S Kesten, DE O’Donnell Respiratory medicine 101 (9), 2017-2024, 2007 | 61 | 2007 |
| Serum periostin in obstructive airways disease J Fingleton, I Braithwaite, J Travers, D Bowles, R Strik, R Siebers, ... European Respiratory Journal 47 (5), 1383-1391, 2016 | 58 | 2016 |
| The value of the CRB65 score to predict mortality in exacerbations of COPD requiring hospital admission L Edwards, K Perrin, M Wijesinghe, M Weatherall, R Beasley, J Travers Respirology 16 (4), 625-629, 2011 | 49 | 2011 |
| The multiple dimensions of airways disease: targeting treatment to clinical phenotypes P Shirtcliffe, M Weatherall, J Travers, R Beasley Current opinion in pulmonary medicine 17 (2), 72-78, 2011 | 42 | 2011 |
| Combination budesonide/formoterol inhaler as maintenance and reliever therapy in M āori with asthma J Pilcher, M Patel, A Smith, C Davies, A Pritchard, J Travers, P Black, ... Respirology 19 (6), 842-851, 2014 | 29 | 2014 |
Mark WeatherallProfessor of Medicine, University of Otago WellingtonVerified email at otago.ac.nz
